IPO
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q4 EPS by 16c, Revenues Beat
-
-
-
-
-
-
-
Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
-
-
-
-
123,283 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

